Eledon Pharmaceuticals, Inc. Operating Income
Eledon Pharmaceuticals, Inc. (ELDN) reported Operating Income of -$22.87 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-13
- Eledon Pharmaceuticals, Inc. operating income (loss) for the quarter ending 2026-06-30 was -$22.87M.
- Eledon Pharmaceuticals, Inc. operating income (loss) for the quarter ending 2026-03-31 was -$21.18M.
- Eledon Pharmaceuticals, Inc. operating income (loss) for the quarter ending 2025-09-30 was -$19.07M.
- Eledon Pharmaceuticals, Inc. operating income (loss) for the quarter ending 2025-06-30 was -$24.73M.
- Eledon Pharmaceuticals, Inc. operating income (loss) for fiscal 2023 was -$43.00M.
- Eledon Pharmaceuticals, Inc. operating income (loss) for fiscal 2022 was -$88.43M.
- Eledon Pharmaceuticals, Inc. operating income (loss) for fiscal 2021 was -$36.87M.
- Eledon Pharmaceuticals, Inc. operating income (loss) for fiscal 2020 was -$18.46M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$22.87M 10-Q · filed 2026-08-13 | -$44.05M 10-Q · filed 2026-08-13 | ||||||
| 2026-03-31 | -$21.18M 10-Q · filed 2026-05-13 | |||||||
| 2025-09-30 | -$19.07M 10-Q · filed 2025-11-14 | -$43.80M derived: sum of 2 quarters · filed 2026-08-13 | -$61.77M 10-Q · filed 2025-11-14 | |||||
| 2025-06-30 | -$24.73M 10-Q · filed 2026-08-13 | -$42.70M 10-Q · filed 2026-08-13 | ||||||
| 2025-03-31 | -$17.96M 10-Q · filed 2026-05-13 | |||||||
| 2024-09-30 | -$20.51M 10-Q · filed 2025-11-14 | -$35.01M derived: sum of 2 quarters · filed 2025-11-14 | -$45.88M 10-Q · filed 2025-11-14 | -$56.22M derived: sum of 4 quarters · filed 2025-11-14 | ||||
| 2024-06-30 | -$14.50M 10-Q · filed 2025-08-14 | -$25.37M 10-Q · filed 2025-08-14 | -$35.71M derived: sum of 3 quarters · filed 2025-08-14 | -$46.91M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | -$10.87M 10-Q/A · filed 2025-08-14 | -$21.21M derived: sum of 2 quarters · filed 2025-08-14 | -$32.41M derived: sum of 3 quarters · filed 2025-08-14 | -$42.76M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2023-12-31 | -$10.34M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$21.54M derived: sum of 2 quarters · filed 2024-11-12 | -$31.89M derived: sum of 3 quarters · filed 2024-11-12 | -$43.00M 10-K · filed 2024-03-28 | ||||
| 2023-09-30 | -$11.20M 10-Q · filed 2024-11-12 | -$21.55M derived: sum of 2 quarters · filed 2024-11-12 | -$32.66M 10-Q · filed 2024-11-12 | -$91.35M derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | -$10.35M 10-Q · filed 2024-08-19 | -$21.46M 10-Q · filed 2024-08-19 | -$80.15M derived: sum of 3 quarters · filed 2024-08-19 | -$90.75M derived: sum of 4 quarters · filed 2024-08-19 | ||||
| 2023-03-31 | -$11.11M 10-Q/A · filed 2024-08-19 | -$69.80M derived: sum of 2 quarters · filed 2024-08-19 | -$80.40M derived: sum of 3 quarters · filed 2024-08-19 | -$89.68M derived: sum of 4 quarters · filed 2024-08-19 | ||||
| 2022-12-31 | -$58.69M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$69.29M derived: sum of 2 quarters · filed 2024-03-28 | -$78.57M derived: sum of 3 quarters · filed 2024-03-28 | -$88.43M 10-K · filed 2024-03-28 | ||||
| 2022-09-30 | -$10.60M 10-Q · filed 2023-11-09 | -$19.88M derived: sum of 2 quarters · filed 2023-11-09 | -$29.74M 10-Q · filed 2023-11-09 | -$39.13M derived: sum of 4 quarters · filed 2023-11-09 | ||||
| 2022-06-30 | -$9.28M 10-Q · filed 2023-08-10 | -$19.14M 10-Q · filed 2023-08-10 | -$28.53M derived: sum of 3 quarters · filed 2023-08-10 | -$39.03M derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | -$9.86M 10-Q · filed 2023-05-11 | -$19.24M derived: sum of 2 quarters · filed 2023-05-11 | -$29.75M derived: sum of 3 quarters · filed 2023-05-11 | -$37.72M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | -$9.38M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$19.89M derived: sum of 2 quarters · filed 2023-03-30 | -$27.86M derived: sum of 3 quarters · filed 2023-03-30 | -$36.87M 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | -$10.51M 10-Q · filed 2022-11-14 | -$18.48M derived: sum of 2 quarters · filed 2022-11-14 | -$27.48M 10-Q · filed 2022-11-14 | -$33.83M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | -$7.97M 10-Q · filed 2022-08-11 | -$16.98M 10-Q · filed 2022-08-11 | -$23.32M derived: sum of 3 quarters · filed 2022-08-11 | -$29.47M derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | -$9.01M 10-Q · filed 2022-05-12 | -$15.35M derived: sum of 2 quarters · filed 2022-05-12 | -$21.50M derived: sum of 3 quarters · filed 2022-05-12 | -$24.09M derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | -$6.35M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | -$12.50M derived: sum of 2 quarters · filed 2022-03-24 | -$15.09M derived: sum of 3 quarters · filed 2022-03-24 | -$18.46M 10-K · filed 2022-03-24 | ||||
| 2020-09-30 | -$6.15M 10-Q · filed 2021-11-12 | -$8.74M derived: sum of 2 quarters · filed 2021-11-12 | -$12.12M 10-Q · filed 2021-11-12 | -$16.28M derived: sum of 4 quarters · filed 2021-11-12 | ||||
| 2020-06-30 | -$2.59M 10-Q · filed 2021-08-12 | -$5.97M 10-Q · filed 2021-08-12 | -$10.14M derived: sum of 3 quarters · filed 2021-08-12 | -$13.06M derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | -$3.38M 10-Q · filed 2021-05-14 | -$7.54M derived: sum of 2 quarters · filed 2021-05-14 | -$10.46M derived: sum of 3 quarters · filed 2021-05-14 | -$14.55M derived: sum of 4 quarters · filed 2021-05-14 | ||||
| 2019-12-31 | -$4.17M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | -$7.09M derived: sum of 2 quarters · filed 2021-03-31 | -$11.18M derived: sum of 3 quarters · filed 2021-03-31 | -$16.05M 10-K · filed 2021-03-31 | ||||
| 2019-09-30 | -$2.92M 10-Q · filed 2020-11-16 | -$7.01M derived: sum of 2 quarters · filed 2020-11-16 | -$11.88M 10-Q · filed 2020-11-16 | -$16.46M derived: sum of 4 quarters · filed 2020-11-16 | ||||
| 2019-06-30 | -$4.09M 10-Q · filed 2020-08-14 | -$8.96M 10-Q · filed 2020-08-14 | -$13.54M derived: sum of 3 quarters · filed 2020-08-14 | -$17.04M derived: sum of 4 quarters · filed 2020-08-14 | ||||
| 2019-03-31 | -$4.88M 10-Q · filed 2020-05-15 | -$9.45M derived: sum of 2 quarters · filed 2020-05-15 | -$12.95M derived: sum of 3 quarters · filed 2020-05-15 | -$16.14M derived: sum of 4 quarters · filed 2020-05-15 | ||||
| 2018-12-31 | -$4.58M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-17 | -$8.08M derived: sum of 2 quarters · filed 2020-03-17 | -$11.27M derived: sum of 3 quarters · filed 2020-03-17 | -$14.06M 10-K · filed 2020-03-17 | ||||
| 2018-09-30 | -$3.50M 10-Q · filed 2019-11-13 | -$6.69M derived: sum of 2 quarters · filed 2019-11-13 | -$9.48M 10-Q · filed 2019-11-13 | -$11.59M derived: sum of 4 quarters · filed 2019-11-13 | ||||
| 2018-06-30 | -$3.19M 10-Q · filed 2019-08-13 | -$5.98M 10-Q · filed 2019-08-13 | -$8.09M derived: sum of 3 quarters · filed 2019-08-13 | -$11.05M derived: sum of 4 quarters · filed 2019-08-13 | ||||
| 2018-03-31 | -$2.79M 10-Q · filed 2019-05-14 | -$4.90M derived: sum of 2 quarters · filed 2019-05-14 | -$7.87M derived: sum of 3 quarters · filed 2019-05-14 | -$14.53M derived: sum of 4 quarters · filed 2019-05-14 | ||||
| 2017-12-31 | -$2.10M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-28 | -$5.07M derived: sum of 2 quarters · filed 2019-03-28 | -$11.74M derived: sum of 3 quarters · filed 2019-03-28 | -$13.12M 10-K · filed 2019-03-28 | ||||
| 2017-09-30 | -$2.96M 10-Q · filed 2018-11-13 | -$9.63M derived: sum of 2 quarters · filed 2018-11-13 | -$11.02M 10-Q · filed 2018-11-13 | -$14.78M derived: sum of 4 quarters · filed 2018-11-13 | ||||
| 2017-06-30 | -$6.67M 10-Q · filed 2018-08-07 | -$8.05M 10-Q · filed 2018-08-07 | -$11.81M derived: sum of 3 quarters · filed 2018-08-07 | -$13.43M derived: sum of 4 quarters · filed 2018-08-07 | ||||
| 2017-03-31 | -$1.39M 10-Q · filed 2018-05-11 | -$3.89M 10-Q · filed 2017-05-03 | -$5.14M derived: sum of 2 quarters · filed 2018-05-11 | -$6.76M derived: sum of 3 quarters · filed 2018-05-11 | -$7.69M derived: sum of 4 quarters · filed 2018-05-11 | |||
| 2016-12-31 | -$3.76M 10-K · filed 2017-03-03 | -$5.38M derived: sum of 2 quarters · filed 2017-11-08 | -$6.31M derived: sum of 3 quarters · filed 2017-11-08 | -$5.13M 10-K · filed 2018-04-02 | -$38.12M 10-K · filed 2017-03-03 | |||
| 2016-09-30 | -$1.62M 10-Q · filed 2017-11-08 | -$9.31M 10-Q · filed 2016-11-03 | -$2.55M derived: sum of 2 quarters · filed 2017-11-08 | -$3.66M 10-Q · filed 2017-11-08 | -$34.36M 10-Q · filed 2016-11-03 | -$25.10M derived: sum of 4 quarters · filed 2017-11-08 | ||
| 2016-06-30 | -$932.00K 10-Q · filed 2017-08-09 | -$13.57M 10-Q · filed 2016-08-04 | -$2.04M 10-Q · filed 2017-08-09 | -$25.05M 10-Q · filed 2016-08-04 | -$23.48M derived: sum of 3 quarters · filed 2017-08-09 | -$35.39M derived: sum of 4 quarters · filed 2017-08-09 | ||
| 2016-03-31 | -$11.48M 10-Q · filed 2017-05-03 | -$22.55M derived: sum of 2 quarters · filed 2017-05-03 | -$34.46M derived: sum of 3 quarters · filed 2017-05-03 | -$43.44M derived: sum of 4 quarters · filed 2017-05-03 | ||||
| 2015-12-31 | -$11.07M 10-K · filed 2017-03-03 | -$22.98M derived: sum of 2 quarters · filed 2017-03-03 | -$31.96M derived: sum of 3 quarters · filed 2017-03-03 | -$45.26M 10-K · filed 2017-03-03 | ||||
| 2015-09-30 | -$11.91M 10-K · filed 2017-03-03 | -$20.89M derived: sum of 2 quarters · filed 2017-03-03 | -$34.19M 10-Q · filed 2016-11-03 | -$40.45M derived: sum of 4 quarters · filed 2017-03-03 | ||||
| 2015-06-30 | -$8.98M 10-K · filed 2017-03-03 | -$22.28M 10-Q · filed 2016-08-04 | -$28.54M derived: sum of 3 quarters · filed 2017-03-03 | -$34.97M derived: sum of 4 quarters · filed 2017-03-03 | ||||
| 2015-03-31 | -$13.30M 10-K · filed 2017-03-03 | -$19.56M derived: sum of 2 quarters · filed 2017-03-03 | -$25.98M derived: sum of 3 quarters · filed 2017-03-03 | -$31.87M derived: sum of 4 quarters · filed 2017-03-03 | ||||
| 2014-12-31 | -$6.26M 10-K · filed 2016-03-10 | -$12.69M derived: sum of 2 quarters · filed 2016-03-10 | -$18.57M derived: sum of 3 quarters · filed 2016-03-10 | -$23.46M 10-K · filed 2017-03-03 | ||||
| 2014-09-30 | -$6.42M 10-K · filed 2016-03-10 | -$12.31M derived: sum of 2 quarters · filed 2016-03-10 | -$17.20M 10-Q · filed 2015-11-10 | -$22.75M derived: sum of 4 quarters · filed 2016-03-10 | ||||
| 2014-06-30 | -$5.88M 10-K · filed 2016-03-10 | -$10.78M 10-Q · filed 2015-08-12 | -$16.33M derived: sum of 3 quarters · filed 2016-03-10 | -$19.69M derived: sum of 4 quarters · filed 2016-03-10 | ||||
| 2014-03-31 | -$4.89M 10-K · filed 2016-03-10 | -$10.44M derived: sum of 2 quarters · filed 2016-03-10 | -$13.81M derived: sum of 3 quarters · filed 2016-03-10 | -$18.25M derived: sum of 4 quarters · filed 2016-03-10 | ||||
| 2013-12-31 | -$5.55M 10-K · filed 2015-03-26 | -$8.91M derived: sum of 2 quarters · filed 2015-03-26 | -$13.36M derived: sum of 3 quarters · filed 2015-03-26 | -$15.75M 10-K · filed 2016-03-10 | ||||
| 2013-09-30 | -$3.37M 10-K · filed 2015-03-26 | -$7.81M derived: sum of 2 quarters · filed 2015-03-26 | -$10.20M 10-Q · filed 2014-11-13 | |||||
| 2013-06-30 | -$4.44M 10-K · filed 2015-03-26 | -$6.83M derived: sum of 2 quarters · filed 2015-03-26 | ||||||
| 2013-03-31 | -$2.39M 10-K · filed 2015-03-26 | |||||||
| 2012-12-31 | -$9.65M 10-K · filed 2015-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |